Glutamate receptors and Parkinson's disease: opportunities for intervention (Q35107721)

6 August 2017

1 reference

title

Glutamate receptors and Parkinson's disease: opportunities for intervention (English)

1 reference

6 August 2017

1 reference

3

P Jeffrey Conn

1 reference

6 August 2017

Michael J Marino

1

1 reference

6 August 2017

Ornella Valenti

series ordinal

2

1 reference

6 August 2017

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

20

1 reference

6 August 2017

issue

5

1 reference

6 August 2017

page(s)

377-397

1 reference

Pharmacological characterization of the metabotropic glutamate receptor inhibiting D-[3H]-aspartate output in rat striatum

6 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00002512-200320050-00006

Subcellular and subsynaptic localization of presynaptic and postsynaptic kainate receptor subunits in the monkey striatum.

21 January 2018

1 reference

12 December 2020

Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease

1 reference

12 December 2020

MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates.

1 reference

12 December 2020

Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease

1 reference

12 December 2020

Subthalamic nucleus cell firing in the 6-OHDA-treated rat: basal activity and response to haloperidol

1 reference

12 December 2020

Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane.

1 reference

12 December 2020

Intravenous amantadine improves levadopa-induced dyskinesias: an acute double-blind placebo-controlled study.

1 reference

12 December 2020

[Effects of oral memantine administration on Parkinson symptoms. Results of a placebo-controlled multicenter study]

1 reference

12 December 2020

Excitatory amino acid neurotransmission: NMDA receptors and Hebb-type synaptic plasticity

1 reference

12 December 2020

The effect of amantadine on levodopa-induced dyskinesias in Parkinson's disease: a double-blind, placebo-controlled study

1 reference

12 December 2020

Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus.

1 reference

12 December 2020

Two populations of kainate receptors with separate signaling mechanisms in hippocampal interneurons

1 reference

12 December 2020

Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study.

1 reference

12 December 2020

GluR1 glutamate receptor subunit is regulated differentially in the primate basal ganglia following nigrostriatal dopamine denervation

1 reference

12 December 2020

The glycine binding site of the N-methyl-D-aspartate receptor subunit NR1: identification of novel determinants of co-agonist potentiation in the extracellular M3-M4 loop region.

1 reference

12 December 2020

Differing effects of N-methyl-D-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeys.

1 reference

12 December 2020

The glutamate receptor ion channels

1 reference

12 December 2020

The antiparkinsonian drug budipine binds to NMDA and sigma receptors in postmortem human brain tissue.

1 reference

12 December 2020

Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease.

1 reference

12 December 2020

Identification of amino acids in the N-methyl-D-aspartate receptor NR1 subunit that contribute to the glycine binding site.

1 reference

12 December 2020

Non-NMDA receptor-mediated mechanisms are involved in levodopa-induced motor response alterations in Parkinsonian rats

1 reference

12 December 2020

Oxidative stress and genetics in the pathogenesis of Parkinson's disease

1 reference

12 December 2020

Enhancement of NMDA responses by group I metabotropic glutamate receptor activation in striatal neurones

1 reference

12 December 2020

Activation of group III metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapse.

1 reference

12 December 2020

Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection.

1 reference

12 December 2020

Metabotropic glutamate receptor agonists inhibit endogenous glutamate release from rat striatal synaptosomes.

1 reference

12 December 2020

N-methyl-D-aspartate-activated channels of mouse central neurones in magnesium-free solutions.

1 reference

12 December 2020

mRNA distribution in adult human brain of GRIN2B, a N-methyl-D-aspartate (NMDA) receptor subunit

1 reference

12 December 2020

Coordinate regulation of metabotropic glutamate receptors

1 reference

12 December 2020

1 reference

12 December 2020

Metabotropic glutamate receptor-mediated presynaptic depression at corticostriatal synapses involves mGLuR2 or 3

1 reference

12 December 2020

LY354740, a group II metabotropic glutamate receptor agonist with potential antiparkinsonian properties in rats.

1 reference

12 December 2020

Amantadine in the Treatment of Parkinson's Disease

1 reference

12 December 2020

Linking Hebb's coincidence-detection to memory formation

1 reference

12 December 2020

Activation of group I metabotropic glutamate receptors produces a direct excitation and disinhibition of GABAergic projection neurons in the substantia nigra pars reticulata.

1 reference

12 December 2020

Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-Dopa in models of Parkinson's disease

1 reference

12 December 2020

Behavioural pharmacology of the non-competitive NMDA antagonists dextrorphan and ADCI: relations between locomotor stimulation, anticataleptic potential and forebrain dopamine metabolism.

1 reference

12 December 2020

Evaluation of dyskinesias in a pilot, randomized, placebo-controlled trial of remacemide in advanced Parkinson disease.

1 reference

12 December 2020

The competitive NMDA receptor antagonist SDZ 220-581 reverses haloperidol-induced catalepsy in rats

1 reference

12 December 2020

Expression of glutamate receptors in the human and rat basal ganglia: Effect of the dopaminergic denervation on AMPA receptor gene expression in the striatopallidal complex in parkinson's disease and rat with 6-OHDA lesion

1 reference

12 December 2020

Antiparkinsonian actions of blockade of NR2B-containing NMDA receptors in the reserpine-treated rat.

1 reference

12 December 2020

Role of the subthalamic nucleus in the regulation of nigral dopamine neuron activity

1 reference

12 December 2020

Amantadine for levodopa-induced dyskinesias: a 1-year follow-up study

1 reference

12 December 2020

The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine-depleted rats and MPTP-treated monkeys

1 reference

12 December 2020

Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion.

1 reference

12 December 2020

Modulation of NMDA receptor function: implications for vertebrate neural development

1 reference

12 December 2020

Roles of NMDA receptor activity and nitric oxide production in brain development

1 reference

12 December 2020

A controlled trial of remacemide hydrochloride in Huntington's disease

1 reference

12 December 2020

Kainate receptor modulation of GABA release involves a metabotropic function

1 reference

12 December 2020

Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced

1 reference

12 December 2020

Genetic regulation of glutamate receptor ion channels

1 reference

12 December 2020

Metabotropic Glutamate Receptor Activation Produces Extrapyramidal Motor System Activation That Is Mediated by Striatal Dopamine

1 reference

12 December 2020

MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in rats

1 reference

12 December 2020

Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions

1 reference

12 December 2020

Subthalamic nucleus neurons switch from single-spike activity to burst-firing mode.

1 reference

12 December 2020

Ionotropic and metabotropic GABA and glutamate receptors in primate basal ganglia.

1 reference

12 December 2020

NMDA receptor antagonists inhibit catalepsy induced by either dopamine D1 or D2 receptor antagonists

1 reference

12 December 2020

Levodopa strengths and weaknesses

1 reference

12 December 2020

NMDA-receptor-dependent synaptic plasticity: multiple forms and mechanisms

1 reference

12 December 2020

AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled, ascending-dose tolerability and safety study of remacemide as adjuvant therapy in Parkinson's disease with response fluctuations.

1 reference

12 December 2020

Effect of RNA editing and subunit co-assembly single-channel properties of recombinant kainate receptors.

1 reference

12 December 2020

Excitotoxicity and the NMDA receptor--still lethal after eight years

1 reference

12 December 2020

Argiotoxin detects molecular differences in AMPA receptor channels.

1 reference

12 December 2020

Biological profile of the metabolites and potential metabolites of the anticonvulsant remacemide

1 reference

12 December 2020

An alanine residue in the M3-M4 linker lines the glycine binding pocket of the N-methyl-D-aspartate receptor.

1 reference

12 December 2020

A pilot study of N-methyl-D-aspartate (NMDA) antagonist in Parkinson's disease

1 reference

12 December 2020

Pathogenesis of Parkinson's disease

1 reference

12 December 2020

Cell-type specificity of mGluR activation in striatal neuronal subtypes.

1 reference

12 December 2020

The AMPA receptor antagonist NBQX does not alter the motor response induced by selective dopamine agonists in MPTP-treated monkeys

1 reference

12 December 2020

LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa-induced motor alterations in Parkinsonian rats

1 reference

12 December 2020

Intrastriatal and intrasubthalamic stimulation of metabotropic glutamate receptors: A behavioral and Fos immunohistochemical study

1 reference

12 December 2020

Activation of group II metabotropic glutamate receptors inhibits synaptic excitation of the substantia Nigra pars reticulata

1 reference

12 December 2020

Hippocampal synaptic plasticity and NMDA receptors: a role in information storage?

1 reference

12 December 2020

Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?

1 reference

12 December 2020

Subthalamic infusion of an NMDA antagonist prevents basal ganglia metabolic changes and nigral degeneration in a rodent model of Parkinson's disease

1 reference

12 December 2020

MK-801 prevents levodopa-induced motor response alterations in parkinsonian rats.

1 reference

12 December 2020

Energetics in the pathogenesis of neurodegenerative diseases

1 reference

12 December 2020

Adjuvant treatment of Parksinson's disease with budipine: a double-blind trial versus placebo.

1 reference

12 December 2020

Relationships between the neuronal sodium/potassium pump and energy metabolism. Effects of K+, Na+, and adenosine triphosphate in isolated brain synaptosomes

1 reference

12 December 2020

Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications.

1 reference

12 December 2020

Dorsal subthalamotomy for Parkinson's disease.

1 reference

12 December 2020

Dextromethorphan improves levodopa-induced dyskinesias in Parkinson's disease

1 reference

12 December 2020

The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

1 reference

12 December 2020

Activation of groups I or III metabotropic glutamate receptors inhibits excitatory transmission in the rat subthalamic nucleus

1 reference

12 December 2020

Metabotropic glutamate receptors and cell-type-specific vulnerability in the striatum: implication for ischemia and Huntington's disease

1 reference

12 December 2020

Efferent projections of the subthalamic nucleus in the rat: light and electron microscopic analysis with the PHA-L method

1 reference

12 December 2020

Chronic but not acute treatment with a metabotropic glutamate 5 receptor antagonist reverses the akinetic deficits in a rat model of parkinsonism.

1 reference

12 December 2020

Mutational analysis of the glycine-binding site of the NMDA receptor: structural similarity with bacterial amino acid-binding proteins

1 reference

12 December 2020

Metabotropic glutamate agonist-induced rotation: a pharmacological, FOS immunohistochemical, and [14C]-2-deoxyglucose autoradiographic study.

1 reference

12 December 2020

1 reference

12 December 2020

Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group

1 reference

12 December 2020

Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease

1 reference

12 December 2020

AMPA receptors: molecular and functional diversity.

1 reference

12 December 2020

Glutamate receptor RNA editing in vitro by enzymatic conversion of adenosine to inosine.

1 reference

12 December 2020

The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics.

1 reference

12 December 2020

(1S,2S)-1-(4-Hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: A Potent New Neuroprotectant Which Blocks N-Methyl-D-Aspartate Responses

1 reference

12 December 2020

Functional changes of the basal ganglia circuitry in Parkinson's disease.

1 reference

12 December 2020

Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes.

1 reference

12 December 2020

A trial of dextromethorphan in parkinsonian patients with motor response complications

1 reference

12 December 2020

Monotherapy of Parkinson's disease with budipine. A double blind comparison with amantadine

1 reference

12 December 2020

MK-801 potentiates dopaminergic D1 but reduces D2 responses in the 6-hydroxydopamine model of Parkinson's disease

1 reference

12 December 2020

Remacemide hydrochloride: a double-blind, placebo-controlled, safety and tolerability study in patients with acute ischemic stroke

1 reference

12 December 2020

Experimental models and behavioural tests used in the study of Parkinson's disease

1 reference

12 December 2020

Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice

1 reference

12 December 2020

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

1 reference

12 December 2020

Activation of metabotropic glutamate receptors inhibits calcium currents and GABA-mediated synaptic potentials in striatal neurons

1 reference

12 December 2020

Acute pharmacologic blockade of dyskinesias in Parkinson's disease

1 reference

12 December 2020

Antiparkinsonian actions of glutamate antagonists--alone and with L-DOPA: a review of evidence and suggestions for possible mechanisms

1 reference

12 December 2020

The GluR2 (GluR-B) hypothesis: Ca(2+)-permeable AMPA receptors in neurological disorders

1 reference

12 December 2020

Magnesium gates glutamate-activated channels in mouse central neurones

1 reference

12 December 2020

CP-101,606, a potent neuroprotectant selective for forebrain neurons.

1 reference

12 December 2020

Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson's disease.

1 reference

12 December 2020

Glutamate and Parkinson's disease

1 reference

12 December 2020

Presynaptic kainate receptors in the monkey striatum

1 reference

12 December 2020

Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression

1 reference

12 December 2020

Molecular determinants of agonist discrimination by NMDA receptor subunits: analysis of the glutamate binding site on the NR2B subunit

1 reference

12 December 2020

(RS)-α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid: Wet dog shakes, catalepsy and body temperature changes in rats

1 reference

12 December 2020

Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat.

1 reference

12 December 2020

Effect of 6-OHDA injection on the AMPA glutamate receptor subunits in the substantia nigra of Sprague-Dawley rats.

1 reference

12 December 2020

MK 801 reverses haloperidol-induced catalepsy from both striatal and extrastriatal sites in the rat brain

1 reference

12 December 2020

Mitochondrial complex I deficiency in Parkinson's disease

1 reference

12 December 2020

Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus

1 reference

12 December 2020

Effect of the NMDA antagonist MK-801 on MPTP-induced parkinsonism in the monkey

1 reference

12 December 2020

The contribution of the different binding sites of the N-methyl-D-aspartate (NMDA) receptor to the expression of behavior

1 reference

12 December 2020

Effects of the prototypical mGlu(5) receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine on rotarod, locomotor activity and rotational responses in unilateral 6-OHDA-lesioned rats

1 reference

12 December 2020

The role of excitotoxicity in neurodegenerative disease: implications for therapy

1 reference

12 December 2020

Synergism of NBQX with dopamine agonists in the 6-OHDA rat model of Parkinson's disease

1 reference

12 December 2020

The NMDA antagonist budipine can alleviate levodopa-induced motor fluctuations

1 reference

12 December 2020

Activation of quisqualate metabotropic receptors reduces glutamate and GABA-mediated synaptic potentials in the rat striatum.

1 reference

12 December 2020

Distribution and roles of metabotropic glutamate receptors in the basal ganglia motor circuit: implications for treatment of Parkinson's disease and related disorders

1 reference

12 December 2020

Reversal of parkinsonian symptoms in primates by antagonism of excitatory amino acid transmission: potential mechanisms of action

1 reference

12 December 2020

Antiparkinsonian actions of CP-101,606, an antagonist of NR2B subunit-containing N-methyl-d-aspartate receptors.

1 reference

12 December 2020

Blockade of the metabotropic glutamate receptor subtype 5 (mGluR5) produces antiparkinsonian-like effects in rats

1 reference

12 December 2020

Subthalamic stimulation-induced synaptic responses in substantia nigra pars compacta dopaminergic neurons in vitro

1 reference

12 December 2020

The NMDA receptor channel: molecular design of a coincidence detector.

1 reference

12 December 2020

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

1 reference

12 December 2020

Interactions between ifenprodil and the NR2B subunit of the N-methyl-D-aspartate receptor

1 reference

12 December 2020

Immunoblot analyses on the differential distribution of NR2A and NR2B subunits in the adult rat brain

1 reference

12 December 2020

Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study

1 reference

12 December 2020

Equilibrium and kinetic study of glycine action on the N-methyl-D-aspartate receptor in cultured mouse brain neurons.

1 reference

12 December 2020

GlycineB antagonists and partial agonists in rodent models of Parkinson's disease--comparison with uncompetitive N-methyl-D-aspartate receptor antagonist

1 reference

12 December 2020

Intraoperative microrecordings of the subthalamic nucleus in Parkinson's disease.

1 reference

12 December 2020

Identification of amino acid residues of the NR2A subunit that control glutamate potency in recombinant NR1/NR2A NMDA receptors

1 reference

12 December 2020

Distinct functional roles of the metabotropic glutamate receptors 1 and 5 in the rat globus pallidus

1 reference

12 December 2020

Activation of group III mGluRs inhibits GABAergic and glutamatergic transmission in the substantia nigra pars reticulata

1 reference

12 December 2020

Prevalence of parkinsonian signs and associated mortality in a community population of older people.

1 reference

12 December 2020

Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease.

1 reference

12 December 2020

Behavioural pharmacology of glutamate receptors in the basal ganglia

1 reference

12 December 2020

NMDA receptor blockade reverses motor response alterations induced by levodopa

1 reference

12 December 2020

Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors.

1 reference

12 December 2020

Centrally-administered glycine antagonists increase locomotion in monoamine-depleted mice

1 reference

12 December 2020

Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation

1 reference

12 December 2020

Differences in Ca2+ permeability of AMPA-type glutamate receptor channels in neocortical neurons caused by differential GluR-B subunit expression

1 reference

12 December 2020

The subthalamic nucleus, hemiballismus and Parkinson's disease: reappraisal of a neurosurgical dogma.

1 reference

12 December 2020

Injection of excitatory amino acid antagonists into the medial pallidal segment of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treated primate reverses motor symptoms of parkinsonism

1 reference

12 December 2020

Antiparkinsonian actions of ifenprodil in the MPTP-lesioned marmoset model of Parkinson's disease

1 reference

12 December 2020

1 reference

12 December 2020

Activation of N-methyl-D-aspartate receptors by glycine: role of an aspartate residue in the M3-M4 loop of the NR1 subunit

1 reference

12 December 2020

Antiparkinsonian action of MK-801 on the reserpine-induced rigidity: a mechanomyographic analysis.

1 reference

12 December 2020

Alternative excitotoxic hypotheses

1 reference

12 December 2020

Milacemide therapy for Parkinson's disease

1 reference

12 December 2020

Molecular determinants of metabotropic glutamate receptor signaling.

1 reference

12 December 2020

Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit

1 reference

12 December 2020

NMDA receptor-dependent excitotoxicity: the role of intracellular Ca2+ release

1 reference

12 December 2020

Budipine is a low affinity, N-methyl-D-aspartate receptor antagonist: patch clamp studies in cultured striatal, hippocampal, cortical and superior colliculus neurones

1 reference

12 December 2020

The competitive NMDA antagonist CPP protects substantia nigra neurons from MPTP-induced degeneration in primates

1 reference

12 December 2020

Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex

1 reference

12 December 2020

Expression of NMDA receptor subunit mRNAs in neurochemically identified projection and interneurons in the human striatum

1 reference

12 December 2020

Microelectrode-guided pallidotomy: technical approach and its application in medically intractable Parkinson's disease

1 reference

12 December 2020

A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease

1 reference

12 December 2020

Functional properties of AMPA and NMDA receptors expressed in identified types of basal ganglia neurons.

1 reference

12 December 2020

The action of N-methyl-D-aspartic acid on mouse spinal neurones in culture.

1 reference

12 December 2020

The role of excitotoxicity and metabolic failure in the pathogenesis of neurological disorders

1 reference

12 December 2020

Primate models of movement disorders of basal ganglia origin

1 reference

12 December 2020

Excitotoxicity and neurodegenerative diseases

1 reference

12 December 2020

Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists

1 reference

12 December 2020

Systemic administration of the NMDA receptor antagonist MK-801 potentiates circling induced by intrastriatal microinjection of dopamine

1 reference

12 December 2020

The AMPAR subunit GluR2: still front and center-stage

1 reference

12 December 2020

A placebo-controlled, double-blind cross-over trial of adjunctive one month remacemide hydrochloride treatment in patients with refractory epilepsy

1 reference

12 December 2020

Role of excitotoxicity in human neurological disease

1 reference

12 December 2020

Antagonist properties of the stereoisomers of ifenprodil at NR1A/NR2A and NR1A/NR2B subtypes of the NMDA receptor expressed in Xenopus oocytes.

1 reference

12 December 2020

Turning behaviour and catalepsy after injection of excitatory amino acids into rat substantia nigra

1 reference

12 December 2020

Permeation and block of N-methyl-D-aspartic acid receptor channels by divalent cations in mouse cultured central neurones

1 reference

12 December 2020

Glycine potentiates the NMDA response in cultured mouse brain neurons

1 reference

12 December 2020

The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism

1 reference

12 December 2020

Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease

1 reference

12 December 2020

Differential subcellular localization of mGluR1a and mGluR5 in the rat and monkey Substantia nigra.

1 reference

12 December 2020

Kainate receptors presynaptically downregulate GABAergic inhibition in the rat hippocampus.

1 reference

12 December 2020

NBQX (6-nitro-sulfamoyl-benzo-quinoxaline-dione) and CPP (3-carboxy- piperazin-propyl phosphonic acid) potentiate dopamine agonist induced rotations in substantia nigra lesioned rats

1 reference

12 December 2020

The antiparkinsonian agent budipine is an N-methyl-D-aspartate antagonist

1 reference

12 December 2020

Pharmacology and functions of metabotropic glutamate receptors

1 reference

12 December 2020

The role of divalent cations in the N-methyl-D-aspartate responses of mouse central neurones in culture

1 reference

12 December 2020

Opposite effects of NMDA and AMPA receptor blockade on catalepsy induced by dopamine receptor antagonists

1 reference

12 December 2020

Calcium entry through kainate receptors and resulting potassium-channel blockade in Bergmann glial cells

1 reference

12 December 2020

Abnormalities of the electron transport chain in idiopathic Parkinson's disease

1 reference

12 December 2020

Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties.

1 reference

12 December 2020

The group II metabotropic glutamate receptor agonist, DCG-IV, alleviates akinesia following intranigral or intraventricular administration in the reserpine-treated rat

1 reference

12 December 2020

Parkinson's disease. First of two parts

1 reference

12 December 2020

Unilateral dopamine depletion increases expression of the 2A subunit of the N-methyl-D-aspartate receptor in enkephalin-positive and enkephalin-negative neurons

1 reference

12 December 2020

Intrastriatal injection of a selective metabotropic excitatory amino acid receptor agonist induces contralateral turning in the rat

1 reference

12 December 2020

Block of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors by polyamines and polyamine toxins.

1 reference

12 December 2020

Models of basal ganglia function and pathophysiology of movement disorders.

1 reference

12 December 2020

Effects of intravenous administration of memantine in parkinsonian patients (author's transl)

1 reference

12 December 2020

Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys

1 reference

12 December 2020

Expression of N-methyl-D-aspartate receptor subunit mRNAs in the human brain: striatum and globus pallidus.

1 reference

12 December 2020

Role of the strychnine-insensitive glycine binding site in the nucleus accumbens and anterodorsal striatum in sensorimotor gating: a behavioral and microdialysis study.

1 reference

12 December 2020

Ca2+ permeability of KA-AMPA--gated glutamate receptor channels depends on subunit composition

1 reference

12 December 2020

Antiparkinsonian action of dextromethorphan in the reserpine-treated mouse

1 reference

12 December 2020

Relationship of activity in the subthalamic nucleus-globus pallidus network to cortical electroencephalogram.

1 reference

12 December 2020

Selective antagonism of native and cloned kainate and NMDA receptors by polyamine-containing toxins

1 reference

12 December 2020

The AMPA antagonists NBQX and GYKI 52466 do not counteract neuroleptic-induced catalepsy

1 reference

12 December 2020

Some central effects of GYKI 52466, a non-competitive AMPA receptor antagonist

1 reference

12 December 2020

Therapeutic brain concentration of the NMDA receptor antagonist amantadine

1 reference

12 December 2020

Memantine, amantadine, and L-deprenyl potentiate the action of L-dopa in monoamine-depleted rats

1 reference

12 December 2020

The antiparkinsonian drugs budipine and biperiden are use-dependent (uncompetitive) NMDA receptor antagonists

1 reference

12 December 2020

Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels

1 reference

12 December 2020

Effects of the antiparkinsonian drug budipine on central neurotransmitter systems.

1 reference

12 December 2020

Posteroventral pallidotomy for Parkinson's disease

1 reference

12 December 2020

Subthalamic nucleus lesion in rats prevents dopaminergic nigral neuron degeneration after striatal 6-OHDA injection: behavioural and immunohistochemical studies

1 reference

12 December 2020

Effect of memantine (NMDA antagonist) on Parkinson's disease: a double-blind crossover randomized study

1 reference

12 December 2020

10.2165/00002512-200320050-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

6 August 2017

1032008706

0 references

1 reference